Sunlenca

Active Ingredient(s): Lenacapavir Sodium
FDA Approved: * December 22, 2022
Pharm Company: * GILEAD SCIENCES INC
Category: HIV / AIDS
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Sunlenca 300 mg Oral Tablet, Film Coated
NDC: 61958-3001
Labeler:
Gilead Sciences
SunlencaSunlenca Kit
NDC: 61958-3002
Labeler:
Gilead Sciences